ArticleThyroid research2026
Maternal thyroid disease and the risk of excessive bleeding in pregnancy: a Danish nationwide cohort study.
Article in Thyroid research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectiveThyroid hormones are involved in the regulation of haemostasis, and it has been hypothesised that abnormal levels of thyroid hormones are associated with an increased risk of excessive bleeding. However, this association is yet to be investigated in pregnant women.
methodsWe performed a retrospective nationwide cohort study of Danish pregnant women from 1999 to 2015. Information on maternal hyperthyroidism and hypothyroidism diagnosed before/during or after the pregnancy, as well as outcomes of bleeding in early and late pregnancy, was collected via the Danish nationwide health registers on hospital diagnoses and drug prescriptions. Multivariate logistic regression was used to calculate adjusted odds ratio (aOR) with a 95% confidence interval (95% CI) for the association between maternal thyroid disease and outcomes of bleeding.
resultsThe study cohort included 1,149,871 pregnancies. Maternal hyperthyroidism was diagnosed in 17,702 pregnancies and hypothyroidism in 27,674 pregnancies. Maternal hyperthyroidism diagnosed before/during (aOR 1.11 (95% CI 1.02;1.21)) and after the pregnancy (aOR 1.11 (95% CI 1.01;1.22)) as well as hypothyroidism diagnosed before/during (aOR 1.11 (95% CI 1.03;1.19)) and after the pregnancy (aOR 1.10 (95% CI 1.02;1.18)) were associated with an increased risk of bleeding in the early pregnancy. For bleeding diagnosed in late pregnancy, we found an association only when maternal hypothyroidism was first diagnosed after the pregnancy (aOR 1.22 (95% CI: 1.07;1.40)).
conclusionIn a large, nationwide cohort, maternal hyperthyroidism and hypothyroidism showed associations with diagnoses of bleeding in pregnancy. Results provide clues on the role of undiagnosed and untreated maternal thyroid disease in pregnancy.
trial registrationNot applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.